Grant name: Assay Validation of High Quality Markers for Clinical Studies in Cancer
Funding organization: National Institutes of Health (NIH), National Cancer Institute (NCI)
Total funding amount: $250,000 per year
Duration: Maximum of 3 years
Primary objective: Validate biomarkers and assays for cancer detection, diagnosis, and treatment response prediction
Key stakeholders: Scientific investigators, oncologists, statisticians, clinical laboratory scientists
Funding source: Federal government
Funding type: Cooperative agreement
Significance: Supports clinical validation of assays critical for cancer studies
Grant frequency: Recurring
Eligible organization types: Higher Education Institutions, Nonprofits, For-Profit Organizations, Local Governments, State Governments, County Governments, City or Township Governments, Indian/Native American Tribal Governments, Federal Agencies, Public Housing Authorities, Faith-based Organizations, Regional Organizations
Specific qualifications: Assays must be analytically validated
Geographic location: U.S. organizations only; foreign organizations are not eligible
Previous relationship with funder: Not specified
Organizational maturity: Not specified
Primary focus areas: Cancer detection, diagnosis, prognosis, monitoring, treatment response prediction
Target beneficiaries: Cancer patients, clinical researchers
Geographic coverage: U.S.
Expected outcomes: Clinical validation of assays, harmonization of clinical laboratory tests
Sustainability expectations: Not specified
Technical expertise: Must include clinical investigators, laboratory staff, and statisticians
Infrastructure: CLIA-certified laboratories preferred for assays supporting medical decision-making
Quality standards: Assays must meet GLP or ISO 17025 standards
Risk management: Not specified
Direct costs limited to $250,000 per year
Maximum project period: 3 years
Cost sharing: Not required
Open date: January 14, 2025
Application due dates: Multiple deadlines until October 14, 2026
Earliest start date: February 14, 2025
Compliance with NIH Grants Policy Statement required
Required registrations: SAM, eRA Commons, Grants.gov
Applications must be submitted electronically via Grants.gov
Follow instructions in the How to Apply - Application Guide
No paper applications accepted
Applications must not propose clinical trials
Focus on validation of existing assays, not early-stage development